US Stock MarketDetailed Quotes

ZURA Zura Bio

Watchlist
  • 2.730
  • -0.200-6.83%
Close Nov 22 16:00 ET
178.25MMarket Cap-4180P/E (TTM)

Zura Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
89.64%19.32M
-65.32%11.76M
8.55%8.38M
130.61%62.64M
10.83M
10.19M
33.91M
7.72M
2,956.91%27.16M
888.55K
Selling and administrative expenses
113.60%13.29M
9.60%6.22M
68.82%4.79M
436.68%18.64M
--3.91M
--6.22M
--5.68M
--2.84M
290.86%3.47M
--888.55K
-General and administrative expense
113.60%13.29M
9.60%6.22M
68.82%4.79M
436.68%18.64M
--3.91M
--6.22M
--5.68M
--2.84M
290.86%3.47M
--888.55K
Research and development costs
52.06%6.03M
-80.38%5.54M
-26.43%3.59M
85.74%44M
--6.92M
--3.97M
--28.23M
--4.88M
--23.69M
----
Operating profit
-89.64%-19.32M
65.32%-11.76M
-8.55%-8.38M
-130.61%-62.64M
-10.83M
-10.19M
-33.91M
-7.72M
-2,956.91%-27.16M
-888.55K
Net non-operating interest income expense
201.96%2.46M
2.2M
121,400.00%1.22M
27,225.00%2.19M
1.37M
815K
0
1K
15,586.27%8K
51
Non-operating interest income
201.96%2.46M
--2.2M
121,400.00%1.22M
27,225.00%2.19M
--1.37M
--815K
--0
--1K
15,586.27%8K
--51
Other net income (expense)
-448.82%-3.84M
-538.33%-766K
71.93%-583K
37.99%-111K
984K
1.1M
-120K
-2.08M
-102.31%-179K
7.74M
Gain on sale of security
-449.55%-3.87M
-504.72%-768K
-442.37%-606K
--2.12M
--960K
--1.11M
---127K
--177K
----
--7.74M
Other non- operating income (expenses)
650.00%22K
-71.43%2K
101.02%23K
-1,144.13%-2.23M
--24K
---4K
--7K
---2.25M
---179K
----
Income before tax
-150.33%-20.7M
69.64%-10.33M
20.91%-7.75M
-121.57%-60.56M
-8.47M
-8.27M
-34.03M
-9.8M
-499.10%-27.33M
6.85M
Income tax
0
0
0
0
0
0
0
0
0
Net income
-150.33%-20.7M
69.64%-10.33M
20.91%-7.75M
-121.57%-60.56M
-8.47M
-8.27M
-34.03M
-9.8M
-499.10%-27.33M
6.85M
Net income continuous Operations
-150.33%-20.7M
69.64%-10.33M
20.91%-7.75M
-121.57%-60.56M
---8.47M
---8.27M
---34.03M
---9.8M
-499.10%-27.33M
--6.85M
Minority interest income
0
0
0
87.27%-203K
0
0
0
-203K
-1.6M
Net income attributable to the parent company
-150.33%-20.7M
69.64%-10.33M
19.23%-7.75M
-134.52%-60.36M
-8.47M
-8.27M
-34.03M
-9.59M
-475.81%-25.74M
6.85M
Preferred stock dividends
Other preferred stock dividends
2.24M
-78.51%2.34M
-3,556.65%-7.02M
33.54%8.88M
-2.2M
0
10.88M
203K
6.65M
Net income attributable to common stockholders
-177.41%-22.94M
71.79%-12.67M
92.55%-730K
-113.78%-69.24M
-6.28M
-8.27M
-44.9M
-9.8M
-572.94%-32.39M
6.85M
Basic earnings per share
-44.44%-0.26
87.02%-0.17
99.28%-0.02
98.53%-2.09
0.13
-0.18
-1.31
-2.76
-572.94%-141.97
30.0184
Diluted earnings per share
-44.44%-0.26
87.02%-0.17
99.28%-0.02
98.53%-2.09
0.13
-0.18
-1.31
-2.76
-572.94%-141.97
30.0184
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 89.64%19.32M-65.32%11.76M8.55%8.38M130.61%62.64M10.83M10.19M33.91M7.72M2,956.91%27.16M888.55K
Selling and administrative expenses 113.60%13.29M9.60%6.22M68.82%4.79M436.68%18.64M--3.91M--6.22M--5.68M--2.84M290.86%3.47M--888.55K
-General and administrative expense 113.60%13.29M9.60%6.22M68.82%4.79M436.68%18.64M--3.91M--6.22M--5.68M--2.84M290.86%3.47M--888.55K
Research and development costs 52.06%6.03M-80.38%5.54M-26.43%3.59M85.74%44M--6.92M--3.97M--28.23M--4.88M--23.69M----
Operating profit -89.64%-19.32M65.32%-11.76M-8.55%-8.38M-130.61%-62.64M-10.83M-10.19M-33.91M-7.72M-2,956.91%-27.16M-888.55K
Net non-operating interest income expense 201.96%2.46M2.2M121,400.00%1.22M27,225.00%2.19M1.37M815K01K15,586.27%8K51
Non-operating interest income 201.96%2.46M--2.2M121,400.00%1.22M27,225.00%2.19M--1.37M--815K--0--1K15,586.27%8K--51
Other net income (expense) -448.82%-3.84M-538.33%-766K71.93%-583K37.99%-111K984K1.1M-120K-2.08M-102.31%-179K7.74M
Gain on sale of security -449.55%-3.87M-504.72%-768K-442.37%-606K--2.12M--960K--1.11M---127K--177K------7.74M
Other non- operating income (expenses) 650.00%22K-71.43%2K101.02%23K-1,144.13%-2.23M--24K---4K--7K---2.25M---179K----
Income before tax -150.33%-20.7M69.64%-10.33M20.91%-7.75M-121.57%-60.56M-8.47M-8.27M-34.03M-9.8M-499.10%-27.33M6.85M
Income tax 000000000
Net income -150.33%-20.7M69.64%-10.33M20.91%-7.75M-121.57%-60.56M-8.47M-8.27M-34.03M-9.8M-499.10%-27.33M6.85M
Net income continuous Operations -150.33%-20.7M69.64%-10.33M20.91%-7.75M-121.57%-60.56M---8.47M---8.27M---34.03M---9.8M-499.10%-27.33M--6.85M
Minority interest income 00087.27%-203K000-203K-1.6M
Net income attributable to the parent company -150.33%-20.7M69.64%-10.33M19.23%-7.75M-134.52%-60.36M-8.47M-8.27M-34.03M-9.59M-475.81%-25.74M6.85M
Preferred stock dividends
Other preferred stock dividends 2.24M-78.51%2.34M-3,556.65%-7.02M33.54%8.88M-2.2M010.88M203K6.65M
Net income attributable to common stockholders -177.41%-22.94M71.79%-12.67M92.55%-730K-113.78%-69.24M-6.28M-8.27M-44.9M-9.8M-572.94%-32.39M6.85M
Basic earnings per share -44.44%-0.2687.02%-0.1799.28%-0.0298.53%-2.090.13-0.18-1.31-2.76-572.94%-141.9730.0184
Diluted earnings per share -44.44%-0.2687.02%-0.1799.28%-0.0298.53%-2.090.13-0.18-1.31-2.76-572.94%-141.9730.0184
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data